{"name":"Center for Epidemiology and Health Research, Germany","slug":"center-for-epidemiology-and-health-research-germany","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-11-01","label":"Progestagen Phase 3 readout (Endometrial Hyperplasia)","drug":"Progestagen","drugSlug":"progestagen","type":"phase3_readout","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-03-30","label":"Progestagen Phase 2 readout (Endometrial Neoplasms, Atypical Endometrial Hyperplasia)","drug":"Progestagen","drugSlug":"progestagen","type":"phase3_readout","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Progestagen","genericName":"Progestagen","slug":"progestagen","indication":"Other","status":"discontinued"}]}],"pipeline":[{"name":"Progestagen","genericName":"Progestagen","slug":"progestagen","phase":"discontinued","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE1kelBVdzBFNkxYeUM5WVlBZXFxdTBkUERpbl9OVnVpb1lraDl1Z3VfMzk2OXRESmpSU3ZianQ0aFpNWlBZYnpNT0dTeFlFOXRWQjdmcERkT3I1SWY0X1dR?oc=5","date":"2025-12-10","type":"pipeline","source":"nature.com","summary":"Mapping the genetic landscape across 14 psychiatric disorders - nature.com","headline":"Mapping the genetic landscape across 14 psychiatric disorders","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxPOWhJMUt0ZEFlUXpZUjd1bXlocnBQNlhtcHpEOS1qR2lqOTQtaGY1T05IQzhtbUVfaHAtY01uSF9veW9GVGRFcTNuOW5sVGNhU2FkZmhNQjZZZ2V3NF8xaG5pay1DaURjRUNKU0I0MHQ4UnpDd2VGSEZmU3E0UnB5R2lyQlFfaXB4bTln?oc=5","date":"2025-10-12","type":"regulatory","source":"The Lancet","summary":"Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a system","headline":"Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 cou","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE8xZ1lFdHF0VXY4Ujh0M3FfclNVV3lxOWpsb29ORXA1d2dEcVhJNF9qRnp1UnFCdTd6Y0h2QzlUTDNwMHJMdnNKVnZ0YWR2Y1RhLXlDQ2ZZa1ZQbGkzRGkw?oc=5","date":"2025-07-21","type":"pipeline","source":"nature.com","summary":"Polygenic prediction of body mass index and obesity through the life course and across ancestries - nature.com","headline":"Polygenic prediction of body mass index and obesity through the life course and across ancestries","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE1HanBvS2JpRFYyOF9MSG5mNjdJVnloMVJCNWlxb3ZtczBrM1VrOENpRHdQZy1aWDJMeHM2X0tNWEpQbG9qZVlrYjkzaFRGYkdTa1lZbklabENnSVVaZ1NZ?oc=5","date":"2025-05-07","type":"trial","source":"nature.com","summary":"Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019 - nature.com","headline":"Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE5xc0oxQ2MxYWREam5lZEdJUWNZd2M4NWk3OEVqdWJ4T0MxcWFKVHhGYnJjc3ZXUldrSFlxdXhFWW5SaXkzeGxFMndCQ1MySVRyNnhyaS1vZmVXOUtaN0R3?oc=5","date":"2025-04-30","type":"pipeline","source":"nature.com","summary":"Global evolution of inflammatory bowel disease across epidemiologic stages - nature.com","headline":"Global evolution of inflammatory bowel disease across epidemiologic stages","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBGd3E1bUJUcEhRZ1BQQ2ozTzluVm9KbHo3OEYzQmpZUC1iVGdhRU9zUkN2azVvYk94QTdVbUZVOHNsVGJrRk53dFVZMnVzNmZrZV8tOTZETklzanZ3Q21r?oc=5","date":"2025-04-22","type":"pipeline","source":"nature.com","summary":"Shaping the future of inflammatory bowel disease: a global research agenda for better management and public health response - nature.com","headline":"Shaping the future of inflammatory bowel disease: a global research agenda for better management and public health respo","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5AFBVV95cUxOck5lSVpidkhSbmdxeW9uWndCamxpckwyTUFDaTJUV0FBM1Z3NkVaTVR3VXFiODlhM0dzOVIyc2ZLd1FKNzMxZzV5MDRXdVk5dVBIcnlRQkpaeGktZ0paT1dNWjY4XzhTclVOMjB1eGNKVjlkWjJJZmJlNkJnMDdPNHFPTkVUaExyalVHNUhwaEgxMnNUOG5uQm5nOGVvSTFGYk9fdTlWbWpJSGQ0aU1rTmIxdXdLUWdfTVNEa3RQSHdTeGJ0aXo4TWZZb0Q5c21WUm1DQkZhODNtd2dveURoTXpWb1k?oc=5","date":"2024-12-10","type":"pipeline","source":"Deloitte","summary":"2025 life sciences outlook - Deloitte","headline":"2025 life sciences outlook","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMia0FVX3lxTE5xdHcwc2VUbDl4X1NYN0ZTa25WaHUwY2lWSUpuT0V2d3otVHJxdkZOd2V0bHRlX0ZzUmpqSUhpT29wNGd0anFjbElpTEFEbFU1NjByTTVYSXVDT1FORVZEV3pWYUFjSkJCM0Zv?oc=5","date":"2024-09-03","type":"pipeline","source":"Wiley Online Library","summary":"Epidemiology of paediatric chronic heart failure in Germany—A population‐based analysis - Wiley Online Library","headline":"Epidemiology of paediatric chronic heart failure in Germany—A population‐based analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE9UTUlscHBlUWpVcG9ZOVJzYXZkSjdVRVdCeE5yZWtpX0l0R3FhTFd2a0NDeEE0WTlBdGxQc01nUEM1Z2lBRXJNSWVUS3VESjZtQy1Cc2NDb3VpTUJ2N0hF?oc=5","date":"2024-06-13","type":"pipeline","source":"nature.com","summary":"A precise performance-based reimbursement model for the multi-centre NAPKON cohorts – development and evaluation - nature.com","headline":"A precise performance-based reimbursement model for the multi-centre NAPKON cohorts – development and evaluation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxPYWVNekpCbkZlVWdCVEhuZm16QnpucERSVURLN0d1X01pOWVVRE5hTVRaSHdvVUZWcWdRQ19pR2NXTmtpYlQ4TFNKR0pHd2s0el9mNlFMNVBxa1czMHFHbGROMEJyV3BKaDlxZkhXdmZxNEhyS0VLVldveVBmc0ttRjNhWnRrdnFleVpBRGNn?oc=5","date":"2024-02-15","type":"pipeline","source":"Frontiers","summary":"Do We Need to Rethink the Epidemiology and Healthcare Utilization of Parkinson's Disease in Germany? - Frontiers","headline":"Do We Need to Rethink the Epidemiology and Healthcare Utilization of Parkinson's Disease in Germany?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxQR2hUVDlIb3lRS00wOHRfX3JEVm9YOFJDTTZkbHBsSWxCbG9mZTNCMkFVX3drdW9fb1J6bFVlUjRoaEh1VnBUUmk4RjNhUnMzOVVqSElFY3VVUFhHNDBqNmNKTUJBc241ZGEycWJFMDdFczBnZ3hSaUs2VFd4UE1ONmxLelZUTkgzOTdwLS1NTFd0dnh6RlE?oc=5","date":"2024-02-05","type":"pipeline","source":"Frontiers","summary":"Interaction between physicians and the pharmaceutical industry: A scoping review for developing a policy brief - Frontiers","headline":"Interaction between physicians and the pharmaceutical industry: A scoping review for developing a policy brief","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxPZEx3amNRaElNOFZEYTduaGQxQ0JlV1JHWWdmTlRPX3B2VVBGVjlmbmZyQ1VRbGo3NmpNd0tTbDFxZkR5T2Rjczh3TEFaYlk0ZjVtc0FQUDBkU0lHY0dWT0t2VkFFT25Ka1VKMWRjRmlhNk9FN19kUERXSU83TFJzSUJsVTBNa3cweG5n?oc=5","date":"2023-09-19","type":"regulatory","source":"The Lancet","summary":"Global burden of peripheral artery disease and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 - The Lancet","headline":"Global burden of peripheral artery disease and its risk factors, 1990–2019: a systematic analysis for the Global Burden ","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"discontinued":1},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}